Shares of Dolby Laboratories (NYSE:DLB – Get Free Report) have earned an average recommendation of “Hold” from the five research firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $76.67.
A number of brokerages have recently commented on DLB. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday. Zacks Research raised Dolby Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, November 13th. Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Robert W. Baird decreased their target price on shares of Dolby Laboratories from $62.00 to $60.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Rosenblatt Securities decreased their target price on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday, November 16th.
Get Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Stock Up 0.8%
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings results on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.05. Dolby Laboratories had a return on equity of 11.77% and a net margin of 18.14%. The company had revenue of $373.54 million for the quarter, compared to analysts’ expectations of $372.76 million. During the same period in the prior year, the firm earned $0.99 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, research analysts anticipate that Dolby Laboratories will post 3.36 earnings per share for the current year.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 9th. Shareholders of record on Tuesday, December 1st will be issued a dividend of $0.39 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $1.56 dividend on an annualized basis and a yield of 2.8%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.36. Dolby Laboratories’s dividend payout ratio (DPR) is presently 53.33%.
Dolby Laboratories announced that its board has approved a share repurchase program on Thursday, July 30th that allows the company to repurchase $350 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Share buyback programs are generally a sign that the company’s board believes its stock is undervalued.
Insider Transactions at Dolby Laboratories
In other news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the transaction, the senior vice president owned 166,803 shares in the company, valued at $9,804,680.34. This trade represents a 4.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares of the company’s stock, valued at $2,249,091.84. The trade was a 3.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 16,517 shares of company stock valued at $995,963. 37.93% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Dolby Laboratories
A number of large investors have recently bought and sold shares of the company. Fulcrum Asset Management LLP increased its holdings in Dolby Laboratories by 733.7% in the third quarter. Fulcrum Asset Management LLP now owns 1,434 shares of the electronics maker’s stock worth $83,000 after purchasing an additional 1,262 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Dolby Laboratories by 130.1% in the third quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker’s stock valued at $85,000 after purchasing an additional 821 shares during the last quarter. Nykredit A S bought a new position in shares of Dolby Laboratories in the second quarter valued at approximately $101,000. Hantz Financial Services Inc. increased its position in shares of Dolby Laboratories by 86.0% during the third quarter. Hantz Financial Services Inc. now owns 2,557 shares of the electronics maker’s stock valued at $150,000 after acquiring an additional 1,182 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Dolby Laboratories during the second quarter worth $216,000. 58.56% of the stock is currently owned by institutional investors and hedge funds.
About Dolby Laboratories
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Further Reading
- Five stocks we like better than Dolby Laboratories
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
